Why the study?
Does hemodynamic-guided heart failure management using a wireless implantable sensor improve NYHA class and reduce heart failure hospitalizations in previously hospitalized outpatients with NYHA class III heart failure?
Does hemodynamic-guided heart failure management using a wireless implantable sensor improve NYHA class and reduce heart failure hospitalizations in previously hospitalized outpatients with NYHA class III heart failure?
In a real-world community setting, hemodynamic-guided HF management using an implantable PAP sensor significantly improved NYHA functional class and reduced HF hospitalizations compared to usual care.
No takes yet. Share an insight, caveat, or question.
May reduce HF hospitalizations and improve NYHA class in outpatients; hypothesis-generating and requires randomized confirmation.
Jermyn et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: